\-\ Texto\\:\\ \ \(0\)\
\-\ \\â\\€\\¢\\ cortical\\ blindness\\.\ \(0\)\
\-\ \\â\\€\\¢\\ positive\\ blood\\ cultures\\.\ \(0\)\
\-\ antibiotics\\ followed\\ by\\ possible\\ aortic\\ valve\\ replacement\\.\ \(0\)\
\-\ \\â\\€\\¢\\ bliateral\\ occipital\\ lobe\\ hemorrhagic\\ lesions\\ with\\ surrounding\\ edema\\.\ \(0\)\
\-\ \\â\\€\\¢\\ minimal\\ entrancement\\ following\\ contrast\\ administration\\.\ \(0\)\
\-\ pyogenic\\ hemorrhagic\\ \\ septic\\ emboli\ \(0\)\
\-\ \\â\\€\\¢\\ trauma\ \(16\)\
\-\ \\â\\€\\¢\\ amyloid\\ angiopathy\ \(0\)\
\-\ \\â\\€\\¢\\ metastatic\\ disease\ \(13\)\
\-\ \\â\\€\\¢\\ septic\\ or\\ mycotic\\ emboli\ \(0\)\
\-\ \\â\\€\\¢\\ hemorrhagic\\ vasculitis\ \(0\)\
\-\ 65\\ year\\ old\\ woman\\ presents\\ with\\ visual\\ problems\\.\\ \\ she\\ had\\ an\\ aortic\\ valve\\ replaced\\ two\\ months\\ ago\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.1931935501967533\ \(0\)\
\-\ hemorrhagic\\:\\ 0\\.16385772684921357\ \(0\)\
\-\ emboli\\:\\ 0\\.12673599128602936\ \(0\)\
\-\ septic\\:\\ 0\\.12287082421041554\ \(0\)\
\-\ bliateral\\:\\ 0\\.12076052635570544\ \(0\)\
\-\ entrancement\\:\\ 0\\.12076052635570544\ \(0\)\
\-\ valve\\:\\ 0\\.11704722306017792\ \(0\)\
\-\ aortic\\:\\ 0\\.09476526436423248\ \(0\)\
\-\ blindness\\:\\ 0\\.0836639482584149\ \(0\)\
\-\ angiopathy\\:\\ 0\\.08194938465630523\ \(0\)\
\-\ pyogenic\\:\\ 0\\.07612906693075364\ \(0\)\
\-\ mycotic\\:\\ 0\\.07612906693075364\ \(0\)\
\-\ amyloid\\:\\ 0\\.07561207613646807\ \(0\)\
\-\ replaced\\:\\ 0\\.07561207613646807\ \(0\)\
\-\ cultures\\:\\ 0\\.06022846323520411\ \(0\)\
\-\ vasculitis\\:\\ 0\\.059902289965427145\ \(0\)\
\-\ replacement\\:\\ 0\\.05713873321678254\ \(0\)\
\-\ 65\\:\\ 0\\.05713873321678254\ \(0\)\
\-\ occipital\\:\\ 0\\.05461924228307119\ \(0\)\
\-\ problems\\:\\ 0\\.05418775369321679\ \(0\)\
\-\ visual\\:\\ 0\\.05306679453913964\ \(0\)\
\-\ administration\\:\\ 0\\.04859808582059137\ \(0\)\
\-\ minimal\\:\\ 0\\.04608876671781915\ \(0\)\
\-\ antibiotics\\:\\ 0\\.04396871722836303\ \(0\)\
\-\ ago\\:\\ 0\\.043571627682154085\ \(0\)\
\-\ cortical\\:\\ 0\\.04267225822706591\ \(0\)\
\-\ possible\\:\\ 0\\.03942441395731605\ \(0\)\
\-\ followed\\:\\ 0\\.039244874950394124\ \(0\)\
\-\ surrounding\\:\\ 0\\.038481715950202264\ \(0\)\
\-\ positive\\:\\ 0\\.03798473411348105\ \(0\)\
\-\ two\\:\\ 0\\.0335250854467946\ \(0\)\
\-\ following\\:\\ 0\\.03322298297124861\ \(0\)\
\-\ edema\\:\\ 0\\.03310854095111357\ \(0\)\
\-\ she\\:\\ 0\\.03286008412950921\ \(0\)\
\-\ trauma\\:\\ 0\\.03201381892819081\ \(0\)\
\-\ months\\:\\ 0\\.03197179855739818\ \(0\)\
\-\ blood\\:\\ 0\\.031950836609716426\ \(0\)\
\-\ lobe\\:\\ 0\\.031497607505801835\ \(0\)\
\-\ lesions\\:\\ 0\\.031336445292382845\ \(0\)\
\-\ metastatic\\:\\ 0\\.029467252104330002\ \(0\)\
\-\ woman\\:\\ 0\\.027039766403957617\ \(0\)\
\-\ contrast\\:\\ 0\\.026202406668601443\ \(0\)\
\-\ had\\:\\ 0\\.02525821670192751\ \(0\)\
\-\ presents\\:\\ 0\\.023912935554903092\ \(0\)\
\-\ by\\:\\ 0\\.01949138223623116\ \(0\)\
\-\ disease\\:\\ 0\\.01913339097555759\ \(0\)\
\-\ an\\:\\ 0\\.016187189921708627\ \(0\)\
\-\ or\\:\\ 0\\.013719489711831609\ \(0\)\
\-\ year\\:\\ 0\\.013097332455793352\ \(0\)\
\-\ old\\:\\ 0\\.01198540543646924\ \(0\)\
\-\ \\.\\:\\ 0\\.003404065105224985\ \(0\)\
\-\ with\\:\\ 0\\.003205593865476431\ \(0\)\
